The importance of Metabolic Syndrome lies in its close association with the risk of CVD and T2DM. Unfortunately its prevalence is increasing to epidemic proportions and the health care costs and burden are substantial. One of the most widely accepted definitions is that provided by the National Cholesterol Education Program guidelines, revised in 2004. In a recent meta-analysis, including 952.083 patients and carried out to assess the prognostic significance of MetS in cardiovascular disease, it was shown that MetS was associated with a BVT.2733 2-fold increase in cardiovascular outcomes and a 1.5-fold increase in all-cause mortality. In turn, excluding the influence of the Darglitazone sodium salt presence of T2DM, this increased risk persists for cardiovascular mortality, acute myocardial infarction and stroke. These data confirmed previously published evidence. From a clinical point of view, there is a debate as to whether the MetS alone or its associated conditions are more important for CVD incidence and mortality or whether prevention and/or treatment of the MetS will reduce CVD incidence and mortality. In this regard, previous observations have reported that the presence of more components of MetS was associated with an increase in subclinical atherosclerosis, and incidence and mortality of coronary heart disease. In the same context, it has been suggested that, in healthy people, there is a relationship between MetS components and exacerbated postprandial lipemia, but there is still a lack of data in patients with CVD. Based on this previous evidence, our objective was to determine if MetS traits influence the postprandial lipemia of coronary patients, and whether this influence depends on the number of MetS criteria. Before starting the test, the patients had fasted for 12 hours and were asked to refrain from smoking during the fasting period and from alcohol intake during the preceding 7 days. They were also asked to avoid strenuous physical activity the day before the test was given. The patients arrived at the clinical center at 08:00 h. We measured anthropometric and blood pressure and biochemical measurements, took a fasting blood sample and under supervision, the patients ingested the fatty food meal. The breakfast was eaten in 20 min.